Stockscreener 앱 받기
4.17
0.71%
-0.03
시장 영업 전:
4.18
0.010
+0.24%
전일 마감가:
$4.20
열려 있는:
$4.24
하루 거래량:
1.21M
Relative Volume:
0.89
시가총액:
$444.49M
수익:
-
순이익/손실:
$-134.24M
주가수익비율:
-2.3559
EPS:
-1.77
순현금흐름:
$-121.34M
1주 성능:
-7.95%
1개월 성능:
-20.27%
6개월 성능:
-25.93%
1년 성능:
-3.92%
1일 변동 폭
$4.105
$4.28
1주일 범위
$3.95
$4.71
52주 변동 폭
$3.86
$8.40
아넥손 Stock (ANNX) Company Profile
명칭
Annexon Inc
전화
(650)-822-5500
주소
1400 SIERRA POINT PARKWAY, BRISBANE
ANNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
4.17 | 444.49M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
아넥손 Stock (ANNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-10-30 | 개시 | Wells Fargo | Overweight |
| 2023-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-05-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-16 | 개시 | Jefferies | Buy |
| 2022-09-09 | 개시 | BTIG Research | Buy |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-09-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-26 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | BofA Securities | Buy |
| 2020-08-18 | 개시 | Cowen | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
모두보기
아넥손 주식(ANNX)의 최신 뉴스
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Buy" by Brokerages - MarketBeat
Guillain-Barré Syndrome Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Chafic Karam, Hansa Biopharma AB, Annexon - The Globe and Mail
Guillain-Barre Syndrome Market to Reach New Heights in Growth - openPR
Annexon (NASDAQ: ANNX) Issues Press Release Outlining 2025 Outlook - Defense World
Hennion & Walsh Asset Management Inc. Boosts Position in Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Short Interest Update - MarketBeat
Barclays PLC Boosts Stake in Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Barclays PLC Acquires 120,789 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year - GlobeNewswire
Annexon Advances Three Breakthrough Therapies, Including First Targeted GBS Treatment - StockTitan
JPMorgan Chase & Co. Has $10.10 Million Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon Expands Board with Appointment of New Member William Jones - Defense World
Annexon Biosciences Strengthens Board for Strategic Growth - TipRanks
Annexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” Jones - GlobeNewswire
Annexon Strengthens Board with Commercial Veteran BJ Jones Ahead of Late-Stage Drug Launches - StockTitan
ANNXAnnexon, Inc. Latest Stock News & Market Updates - StockTitan
Jane Street Group LLC Sells 39,601 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon: Breakthrough In Guillain-Barré Faces Upcoming FDA Hurdles (NASDAQ:ANNX) - Seeking Alpha
Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Annexon (NASDAQ:ANNX) Stock Price Down 4.3%Here's Why - MarketBeat
Franklin Resources Inc. Acquires Shares of 49,406 Annexon, Inc. (NASDAQ:ANNX) - Defense World
Barclays PLC Has $1.05 Million Holdings in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Geode Capital Management LLC Grows Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon, Inc. (NASDAQ:ANNX) Shares Purchased by Geode Capital Management LLC - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Annexon, Inc. (NASDAQ:ANNX) Shares Purchased by State Street Corp - Defense World
Annexon (ANNX) Surges with Promising Phase 3 Results for Guillain-Barré Syndrome Treatment - TipRanks
State Street Corp Has $22.74 Million Stake in Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Annexon (NASDAQ:ANNX) Shares Down 3.8%Time to Sell? - MarketBeat
HC Wainwright Reaffirms Buy Rating for Annexon (NASDAQ:ANNX) - Defense World
New Data Supports BLA Package - Streetwise Reports
Annexon (NASDAQ:ANNX) Given Buy Rating at HC Wainwright - MarketBeat
Annexon shares rise on positive Guillain-Barré study results By Investing.com - Investing.com Australia
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Annexon Awards Major Stock Options Package to New Hires in Strategic Talent Acquisition Move - StockTitan
Annexon shares rise on positive Guillain-Barré study results - Investing.com
Annexon (NASDAQ:ANNX) Shares Gap UpWhat's Next? - MarketBeat
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS) - The Manila Times
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 - The Bakersfield Californian
Annexon's ANX005 Shows Breakthrough Results in Guillain-Barré Treatment, Outperforms Standard Therapy - StockTitan
Charles Schwab Investment Management Inc. Boosts Stock Position in Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
The Manufacturers Life Insurance Company Buys 2,450 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
MetLife Investment Management LLC Acquires 5,814 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Intech Investment Management LLC Purchases Shares of 26,013 Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon, Inc. (NASDAQ:ANNX) Stock Holdings Raised by Fmr LLC - Defense World
Fmr LLC Has $50.69 Million Holdings in Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Holdings Lowered by Point72 Asset Management L.P. - MarketBeat
Readystate Asset Management LP Reduces Stake in Annexon, Inc. (NASDAQ:ANNX) - MarketBeat
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting - The Manila Times
Annexon to Present Phase 2 ARCHER Data on Protection of - GlobeNewswire
아넥손 (ANNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):